Developments in proton MR spectroscopic imaging of prostate cancer

MAGMA. 2022 Aug;35(4):645-665. doi: 10.1007/s10334-022-01011-9. Epub 2022 Apr 20.

Abstract

In this paper, we review the developments of 1H-MR spectroscopic imaging (MRSI) methods designed to investigate prostate cancer, covering key aspects such as specific hardware, dedicated pulse sequences for data acquisition and data processing and quantification techniques. Emphasis is given to recent advancements in MRSI methodologies, as well as future developments, which can lead to overcome difficulties associated with commonly employed MRSI approaches applied in clinical routine. This includes the replacement of standard PRESS sequences for volume selection, which we identified as inadequate for clinical applications, by sLASER sequences and implementation of 1H MRSI without water signal suppression. These may enable a new evaluation of the complementary role and significance of MRSI in prostate cancer management.

Keywords: Prostate cancer; Proton magnetic resonance spectroscopy; Spectroscopic imaging; State-of-the-art review.

Publication types

  • Review

MeSH terms

  • Humans
  • Magnetic Resonance Imaging / methods
  • Magnetic Resonance Spectroscopy / methods
  • Male
  • Prostatic Neoplasms* / diagnostic imaging
  • Proton Magnetic Resonance Spectroscopy / methods
  • Protons*

Substances

  • Protons